Skip to main content
. 2021 May 26;25(14):6558–6572. doi: 10.1111/jcmm.16655

FIGURE 6.

FIGURE 6

The expression level of CCL4, CCL5, CXCL9, CXCL10 and CXCL13 in serum of CHB therapeutic non‐responders were lower than that of responders at baseline and at 16 weeks of treatment. *P <.05, **P <.01